Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial.

Autor: Sinha SD; Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate, 7-2-A2, Industrial Estates, Sanath Nagar, Hyderabad, Andhra Pradesh, India., Bandi VK; Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate, 7-2-A2, Industrial Estates, Sanath Nagar, Hyderabad, Andhra Pradesh, India., Bheemareddy BR; Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate, 7-2-A2, Industrial Estates, Sanath Nagar, Hyderabad, Andhra Pradesh, India., Thakur P; Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate, 7-2-A2, Industrial Estates, Sanath Nagar, Hyderabad, Andhra Pradesh, India. Pankaj.Thakur@heterodrugs.com., Chary S; Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate, 7-2-A2, Industrial Estates, Sanath Nagar, Hyderabad, Andhra Pradesh, India., Mehta K; Department of Nephrology, B.L.Y Nair Hospital, A.L Nair Road, Mumbai, Maharashtra, India., Pinnamareddy VR; Care Hospitals, Road No. 1, Banjara Hills, Hyderabad, Andhra Pradesh, India., Pandey R; Department of Nephrology, Institute of Post Graduate Medical Education and Research Kolkata, 244 A.J.C Bose Road, Kolkata, West Bengal, India., Sreepada S; Sri Raghavendra Hospital, 1-7-100, Opp. Round Building, Kamala Nagar, ECIL Cross Road, ECIL, Hyderabad, Andhra Pradesh, 500062, India., Durugkar S; Ashwini Hospital and Ramakanth Heart Care Center, Shivaji Nagar, Nanded, Maharashtra, India.

Publikováno v: BMC nephrology [BMC Nephrol] 2019 Nov 19; Vol. 20 (1), pp. 415. Date of Electronic Publication: 2019 Nov 19.